ESC 365 - Medium term improvement in left ventricular systolic function following CRT pacemaker implantation indicates additional defibrillator component may not be necessary

HFA Premium Access

Medium term improvement in left ventricular systolic function following CRT pacemaker implantation indicates additional defibrillator component may not be necessary

Session: Chronic heart failure - treatment 3

Topic: Cardiac Resynchronisation Therapy (CRT)

Speaker: Doctor H. Shabbir (Blackburn, GB)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Haroon Shabbir

East Lancashire Hospitals NHS Trust, Blackburn (United Kingdom of Great Britain & Northern Ireland)

0 follower

4 more presentations in this session

Efficacy of dapagliflozin according to heart rate in patients with heart failure: a patient-level pooled analysis of DAPA-HF and DELIVER

Speaker: Doctor T. Kondo (Glasgow, GB)

Calcium channel blocker and outcomes in patients with heart failure and mildly reduced or preserved ejection fraction

Speaker: Doctor S. Matsumoto (Tokyo, JP)

Patient characteristics, outcomes, and effects of dapagliflozin according to the duration of heart failure: a prespecified analysis of the DELIVER trial

Speaker: Doctor T. Kondo (Glasgow, GB)

Left bundle branch block cardiomyopathy: an intriguing and defiant entity from diagnosis to treatment

Speaker: Ms C. Oliveira (Porto, PT)

Access the full session

Chronic heart failure - treatment 3

Speakers: Doctor H. Shabbir, Doctor T. Kondo, Doctor S. Matsumoto, Doctor T. Kondo, Ms C. Oliveira

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources